News

Biogen pledges $2 billion to grow NC's RTP campuses amid pharma tariff threats
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...
Biogen to invest $2 billion in RTP, open new factory in 2025
Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...
Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome
In February 2025, Biogen Inc. (NASDAQ:BIIB) formed a partnership with Stoke Therapeutics to develop zorevunersen for Dravet ...
Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing
Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...
BioSpace9h
Biogen Commits $2B To Expand US Drug Production Amid Tariff Talk
The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...
Biogen (BIIB) Stock Trades Down, Here Is Why
Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock ...
Explore more
Biogen Inc. stock underperforms Monday when compared to competitors
This was the stock's second consecutive day of losses.
Barchart on MSN3d
Here's What to Expect From Biogen's Next Earnings Report
Valued at a market cap of $18.9 billion, Biogen Inc. (BIIB) is a biotechnology company that discovers, develops, manufactures ...